2Prof. Dr. MD, Celal Bayar University Medical Faculty, Ophthalmology Department, Manisa, Turkey DOI : 10.37844/glauc.cat.2021.16.17 Purpose: Transscleral diode laser cyclophotocoagulation is preferred in patients refractory to medical and surgical treatment modalities. In our study, it was aimed to assess effi cacy of diode laser cyclophotocoagulation in reducing intraocular pressure in refractory glaucoma patients.
Material and Methods: The study included patients followed with diagnosis of refractory glaucoma; newly diagnosed refractory glaucoma patients presented to our glaucoma clinic between January 2008 and May 2011. In all patients, visual acuity, intraocular pressure as measured by Goldmann applanation tonometry, fi ndings of slit-lamp examination and fundus examination, glaucoma type, number of medications, previous glaucoma surgeries were recorded at baseline. In all patients, intraocular pressure was measured at baseline and on day 1, on week 1and 6, and at month 3, 6 and 12 after treatment.
Results: The study included 49 of 49 patients (18 female, 29 male). Mean age was 61.4±12.8 years. In the study group, there were 25 patients (%51.2) with neovascular glaucoma, 9 patients (%18.4) with primary open angle glaucoma, 6 patients (%12.2) with primary angle closure glaucoma, 4 patients (%8.2) with pseudoexfoliation glaucoma and 5 patients (%10.2) with secondary glaucoma. Mean intraocular pressure was 44.1±11.3 mmHg at baseline, which reduced to 17.0±9.8 mmHg at year 1 (%63.4) (p<0.05). £22 mmHg intraocular pressure was achieved in 37 of 49 eyes (%75.5) while an intraocular pressure reduction by ?30% from baseline was achieved in 33 of the 49 eyes (%87.8).
Conclusion: Transscleral diode laser cyclophotocoagulation is a safe and effective treatment modality for refractory glaucoma patients with poor prognosis and uncontrolled intraocular pressure with medical and surgical treatment modalities.
Keywords : Refractory glaucoma management, Intraocular pressure, Transscleral diode laser cyclophotocoagulation